Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atezolizumab and Bevacizumab in Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07285850
What this trial is testing

The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD

Who this might be right for
HCC - Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT05440708
What this trial is testing

TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tvardi Therapeutics, Incorporated 193
Large-scale testing (Phase 3)Active Not RecruitingNCT05904886
What this trial is testing

A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

Who this might be right for
Hepatocellular Carcinoma
Hoffmann-La Roche 687
Testing effectiveness (Phase 2)Looking for participantsNCT05528952
What this trial is testing

Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Centre Hospitalier Universitaire de Besancon 105
Testing effectiveness (Phase 2)Study completedNCT05750030
What this trial is testing

FMT in IT-refractory HCC - FAB-HCC Pilot Study

Who this might be right for
Hepatocellular Carcinoma
Medical University of Vienna 12
Testing effectiveness (Phase 2)Study completedNCT04829383
What this trial is testing

Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma
Howard S Hochster 6
Testing effectiveness (Phase 2)Looking for participantsNCT05690048
What this trial is testing

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)

Who this might be right for
ImmunotherapyHCC - Hepatocellular Carcinoma
Michael Dill 48
Not applicableEnded earlyNCT05705791
What this trial is testing

Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 10
Not applicableActive Not RecruitingNCT07204327
What this trial is testing

Atezolizumab Plus Bevacizumab Combined With Locoregional Therapies in Unresectable Hepatocellular Carcinoma (ISMIO-001)

Who this might be right for
Unresectable Hepatocellular Carcinoma
Zhongda Hospital 1,136
Testing effectiveness (Phase 2)Looking for participantsNCT06339424
What this trial is testing

Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chang Gung Memorial Hospital 45
Not applicableStudy completedNCT04862949
What this trial is testing

Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma
CHA University 131
Testing effectiveness (Phase 2)Ended earlyNCT05537402
What this trial is testing

LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC

Who this might be right for
Hepatocellular Carcinoma
University of Texas Southwestern Medical Center 1
Not applicableStudy completedNCT06503250
What this trial is testing

Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevacizumab Plus Transarterial Chemoembolization

Who this might be right for
Unresectable Hepatocellular Carcinoma
Hoffmann-La Roche 113
Large-scale testing (Phase 3)Study completedNCT04487067
What this trial is testing

Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Patients With Unresectable Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy-Amethista

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 152
Early research (Phase 1)Ended earlyNCT05093608
What this trial is testing

SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Ended earlyNCT05199285
What this trial is testing

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+8 more
Academic and Community Cancer Research United 15
Large-scale testing (Phase 3)Ended earlyNCT04732286
What this trial is testing

Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 100
Not applicableUnknownNCT05879328
What this trial is testing

The ImmunoXXL Study

Who this might be right for
Hepatocellular Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04712643
What this trial is testing

TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma

Who this might be right for
Hepatocellular Carcinoma
Hoffmann-La Roche 342
Not applicableStudy completedNCT06199297
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 188
Next Page